SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-043513
Filing Date
2017-08-15
Accepted
2017-08-15 16:17:10
Documents
1
Period of Report
2017-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 v473387_form4.html 4  
1 FORM 4 v473387_form4.xml 4 4114
  Complete submission text file 0001144204-17-043513.txt   5700
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Issuer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MEDGENICS, INC. 435 DEVON PARK DRIVE, BLDG. 700 WAYNE PA 19087
Business Address
Piper Brian (Reporting) CIK: 0001665924 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35112 | Film No.: 171034100